Jakafi

Spezifikationen

1092939-17-7CAS-Nummer

641-390-8EG-Nummer

(3R)-3-cyclopentyl-3-[4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)pyrazol-1-yl]propanenitrile;phosphoric acidIUPAC-Name

C17H21N6O4PChemische Formel

404.4 g/molMolekulargewicht

Ruxolitinib phosphate; 1092939-17-7; Jakafi; INCB-018424 phosphate; ruxolitinib monophosphate; INCB018424 PHOSPHATE; ruxolitinib (as phosphate); INCB-018424 Salt; 436LRU32H5; (3R)-3-cyclopentyl-3-[4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl]propanenitrile phosphate; INCB-18424 PHOSPHATE; CHEBI:66917; 1H-Pyrazole-1-propanenitrile, beta-cyclopentyl-4-(7H-pyrrolo(2,3-d)pyrimidin-4-yl)-,(betaR)-, phosphate (1:1); (3R)-3-cyclopentyl-3-(4-(7H-pyrrolo(2,3-d)pyrimidin-4-yl)-1H-pyrazol-1-yl)propanenitrile phosphate; RefChem:55991; (3R)-3-cyclopentyl-3-(4-(7h-pyrrolo(2,3-d)pyrimidin-4-yl)pyrazol-1-yl)propanenitrile Phosphate (1:1); (R)-3-(4-(7H-Pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl)-3-cyclopentylpropanenitrile phosphate; Jakavi; Ruxolitinib (phosphate); MFCD18452860; Ruxolitinib phosphate [USAN]; OPZELURA; (betaR)-beta-Cyclopentyl-4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazole-1-propanenitrile phosphate; Ruxolitinib phosphate salt; INCB018424 SALT; (3R)-3-cyclopentyl-3-[4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)pyrazol-1-yl]propanenitrile;phosphoric acid; phosphenoperoxoic acid compound with (R)-3-(4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)- 1H-pyrazol-1-yl)-3-cyclopentylpropanenitrile and dihydrogen (1:1:1); UNII-436LRU32H5; Opzelura (TN); (3R)-3-Cyclopentyl-3-(4-(7H-pyrrolo(2,3-d)pyrimidin-4-yl)-1H-pyrazol-1-yl)propanenitrile phosphate (1:1); (3R)-3-Cyclopentyl-3-[4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl]propanenitrile phosphate (1:1); 1H-Pyrazole-1-propanenitrile, ss-cyclopentyl-4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-, (ssR)-, phosphate (1:1); INC 424 phosphate; INCB 018424 phosphate; Jakafi; Ruxolitinib phosphate; 1092939-17-7 (phosphate); Jakafi (TN); Jakavi (TN); Ruxolitinib phosphate(INCB018424); INCB 018424 phosphate; INCB-424; orb1227003; orb1304597; SCHEMBL1369365; CHEMBL1795071; SCHEMBL29357426; C17H21N6O4P; DTXSID00911086; JFMWPOCYMYGEDM-XFULWGLBSA-N; GLXC-90413; HMS6018G03; Ruxolitinib phosphate (JAN/USAN); RUXOLITINIB PHOSPHATE [MI]; RUXOLITINIB PHOSPHATE [JAN]; (R)-3-(4-(7H-Pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl)-3-cyclopentylpropanenitrile phosphate;Beta-cyclopentyl-4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-(Betar)-1H-pyrazole-1-propanenitrile, phosphate; EX-A2660; CS1956; EBC-78035; s5243; AKOS024464417; RUXOLITINIB PHOSPHATE [WHO-DD]; CCG-268687; CS-0326; AC-30901; AS-74723; FR167906; HY-50858; SY069211; RUXOLITINIB PHOSPHATE [ORANGE BOOK]; T3043; RUXOLITINIB (AS PHOSPHATE) [EMA EPAR]; D09960; F979379; Q27135517; (3R)-3-cyclopentyl-3-(4-{7H-pyrrolo[2,3-d]pyrimidin-4-yl}-1H-pyrazol-1-yl)propanenitrile; phosphoric acid; (R)-3-Cyclopentyl-3-[4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1-pyrazolyl]propanenitrile Phosphate; 1H-Pyrazole-1-propanenitrile, .beta.-cyclopentyl-4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-, (.beta.R)-, phosphate (1:1); 1H-Pyrazole-1-propanenitrile, beta-cyclopentyl-4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-, (betaR)-, phosphate (1:1); Phosphoric acid--(3R)-3-cyclopentyl-3-[4-(1H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl]propanenitrile (1/1); Phosphoric acid--3-cyclopentyl-3-[4-(1H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl]propanenitrile (1/1)Synonyme